Altimmune (ALT) Preferred Dividend Payments (2016 - 2019)
Altimmune's (ALT) quarterly Preferred Dividend Payments came in at $452925.0 in Q1 2019, down 76.05% year-on-year from $1.9 million in Q1 2018, and down 41.97% on a QoQ basis from $780525.0 in Q4 2018.
Altimmune (ALT) Preferred Dividend Payments (2016 - 2019) Analysis & Trends
Altimmune (ALT) has 4 years of Preferred Dividend Payments data on file, last reported at $452925.0 in Q1 2019.
- On a quarterly basis, Preferred Dividend Payments fell 76.05% year-over-year to $452925.0 in Q1 2019; TTM through Dec 2019 was $452925.0, a 86.31% decrease from a year earlier, with the FY2019 full-year figure at $452925.0, down 86.31% from the prior year.
- Preferred Dividend Payments for Q1 2019 stood at $452925.0, down from $780525.0 in the prior quarter.
- Over the last five years, Preferred Dividend Payments for ALT reached as high as $2.8 million in Q4 2017 and fell as low as -$64139.0 in Q3 2018.
- Historically, Preferred Dividend Payments has averaged $750282.7 across 4 years, with a median of $286955.5 in 2016.
- Across the five-year window, Preferred Dividend Payments jumped 2218.34% in 2017 and sank 103.27% in 2018, its largest moves.
- Year by year, Preferred Dividend Payments stood at $120986.0 in 2016, then soared by 2218.34% to $2.8 million in 2017, then slumped by 72.17% to $780525.0 in 2018, then plunged by 41.97% to $452925.0 in 2019.
- Per Business Quant data, the three most recent Preferred Dividend Payments figures were $452925.0 in Q1 2019, $780525.0 in Q4 2018, and -$64139.0 in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Altimmune | 346.63 Mn | 346.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 452,925.00 |
| Dec 31, 2018 | 780,525.00 |
| Sep 30, 2018 | -64,139.00 |
| Jun 30, 2018 | 700,093.00 |
| Mar 31, 2018 | 1.89 Mn |
| Dec 31, 2017 | 2.80 Mn |
| Sep 30, 2017 | 1.96 Mn |
| Jun 30, 2017 | 44,713.00 |
| Mar 31, 2017 | 118,356.00 |
| Dec 31, 2016 | 120,986.00 |
| Sep 30, 2016 | 104,548.00 |
| Jun 30, 2016 | 87,123.00 |